August 12, 2024 – The U.S. Meals and Drug Administration has authorised Neffy (epinephrine nasal spray) for the emergency remedy of allergic (sort I) reactions, together with reactions which might be life-threatening (anaphylaxis), in grownup and pediatric sufferers weighing at the very least 30 kilograms (about 66 kilos).

Neffy is a single-dose nasal spray administered into one nostril. As with epinephrine injection merchandise, a second dose (utilizing a brand new nasal spray to manage Neffy into the identical nostril) could also be given if there is no such thing as a enchancment in signs or if signs worsen. Sufferers may have to hunt emergency medical consideration for shut monitoring of the anaphylactic episode and in case additional remedy is required.

Neffy’s approval relies on 4 research involving 175 wholesome adults, with out anaphylaxis, during which blood epinephrine concentrations had been measured after administration of Neffy or authorised epinephrine injection merchandise. Outcomes from these research confirmed comparable epinephrine blood concentrations between Neffy and authorised epinephrine injection merchandise. Neffy additionally confirmed comparable will increase in blood stress and coronary heart fee as epinephrine injection merchandise, two vital results of epinephrine in treating anaphylaxis. A research of Neffy in youngsters weighing greater than 66 kilos confirmed that epinephrine concentrations in youngsters had been similar to these of adults who acquired Neffy.

Extra info